Skip to main content

CITADEL ADVISORS LLC

Position in BBOT — BridgeBio Oncology Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Position in BBOT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$19,947,841
-$2,684,578 QoQ
Shares Held
2,617,827
+3.5% QoQ
Ownership
3.27%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#8
of 66 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BBOT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. BBOT ranks #60 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BBOT

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,947,841 2,617,827
2026-03-31 $22,632,419 2,528,762
2025-12-31 $31,679,656 2,530,324
2025-09-30 $29,391,671 2,538,141
2025-06-30 HLXB 1,427,201
2025-03-31 HLXB 1,411,960
2024-12-31 HLXB 1,339,670
2024-09-30 HLXB 1,332,650
2024-06-30 HLXB 1,332,508
2024-03-31 HLXB 1,332,453